Cardiogen is a four-amino-acid peptide from Vladimir Khavinson's St. Petersburg group. The sequence, Ala-Glu-Asp-Arg, is consistent across the patent, the papers and the group's reviews.
Cardiogen Prices
8 vendors · 0 with an issuer-verified COA · lowest 10mg from $33.39 · checked
Where to buy Cardiogen: 8 vendors compared
| Vendor | Price | Actions |
|---|---|---|
| $33.3910mg packageChecked today | Buy Cardiogen from Regenix Peptides | |
| $47.99 | Buy Cardiogen from Cenexa Labs | |
| $48.75 | Buy Cardiogen from Atomik Labz | |
| $53.5120mg packageChecked today | Buy Cardiogen from Kensington Labs | |
| $55.24 | Buy Cardiogen from SomaChems | |
| $62.97 | Buy Cardiogen from BioLongevity Labs | |
| $76.00 | Buy Cardiogen from Paramount Peptides | |
| $89.10 | Buy Cardiogen from Nationwide Peptides |
Tracked every day
Cardiogen listing prices, tracked daily
The five cheapest in-stock package prices for Cardiogen on each collected day, and the vendors that most often held those places.
No collected listings for this compound yet.
Current market data
Cardiogen Price Report
A current summary of public listings after the price comparison above. Shipping and tax are not included.
The lowest current 10mg cost for Cardiogen is $33.39 from Regenix Peptides. The median across vendors is $54.38.
- Lowest 10mg cost
- $33.39Regenix Peptides
- Median 10mg cost
- $54.38One normalized offer per vendor
- Lowest package total
- $33.39Regenix Peptides · package size may differ
- Public COA coverage
- 100%8 of 8 vendors
What the market shows
PeptidePrices found 8 in-stock listings from 8 vendors, checked through Oct 8, 2026. The lowest 10mg cost is 39% below the vendor median of $54.38; 4 vendors (50%) fall below that median. 8 of 8 vendors (100%) publish public COA evidence.
A public COA link shows that a vendor publishes testing data. It does not prove that every listed vial has a matching current report. Match the product, strength, batch, and lot before relying on a report.
How this report is calculated
The headline and median use each vendor's lowest whole-package checkout cost to obtain at least 10mg. Smaller packages are multiplied until the target is met, while larger packages retain their full checkout price. The lowest package total is shown only as secondary context because package sizes differ. Known public coupon discounts are applied. Shipping, tax, and unverified promotions are excluded.
Research context
What is Cardiogen? Research, safety, and status
Cardiogen is a synthetic tetrapeptide: alanine, glutamic acid, aspartic acid, arginine. The developers say it was identified in a heart polypeptide complex by chromatography-mass spectrometry and then made synthetically. The proposed mechanism is the group's standard one for short peptides: entry into the nucleus, binding to DNA or histones, and a shift in gene expression.
For AEDR in particular, the direct evidence for that mechanism is one test-tube study showing it binds fluorescently labeled wheat histones, alongside five other short peptides. A 2023 paper from the group ran computer docking against the LAT1, LAT2 and PEPT1 transporters and listed AEDR among the best-scoring ligands. Docking scores are predictions, not measured uptake.
Key research takeaways
The heart claims rest mostly on the developers' own 2004 US patent: rat infarction, isolated-heart and arrhythmia experiments that were never published as peer-reviewed papers that we could find. The group's 2022 review cites the patent itself as the source of its in vivo heart data.
The peer-reviewed record is small: rat heart-tissue explants, mouse embryonic fibroblasts, a test-tube histone-binding study, and one rat tumor study that did not look at the heart.
No human trial exists in PubMed or ClinicalTrials.gov.
The name collides with two unrelated things: CardioGen-82, an FDA-approved rubidium generator for cardiac PET scans, and a PubChem synonym for L-carnitine. Search by sequence.
Cardiogen at a glance
PeptidePrices safety rating
6/10 · Not FDA-approved
Mechanism
Proposed bioregulator of heart and vascular tissue; organotypic culture and rat studies report effects on cell growth and tumor-cell apoptosis.
Research areas
Heart and cardiovascular-tissue bioregulator research. Human clinical benefit is not established.
Regulatory / research status
Research / preclinical only
Half-life
Not established in direct human pharmacokinetic studies.
Storage
Lyophilized vial: store at -20°C long-term or 2-8°C short-term, protected from light.
Reported side effects
Human safety data is sparse. The available evidence is mainly preclinical and small Russian studies from one research group, and it does not establish clinical efficacy.
Russian bioregulator; short peptide; limited but clean data. Human evidence is thin and mostly from one research group. Safety ratings summarize published clinical data, adverse-event reporting, and regulatory status. How PeptidePrices rates evidence. Research information only, not medical advice.
Study highlights
- Cardiogen is a four-amino-acid peptide from Vladimir Khavinson's St. Petersburg group. The sequence, Ala-Glu-Asp-Arg, is consistent across the patent, the papers and the group's reviews.
- The heart claims rest mostly on the developers' own 2004 US patent: rat infarction, isolated-heart and arrhythmia experiments that were never published as peer-reviewed papers that we could find. The group's 2022 review cites the patent itself as the source of its in vivo heart data.
- The peer-reviewed record is small: rat heart-tissue explants, mouse embryonic fibroblasts, a test-tube histone-binding study, and one rat tumor study that did not look at the heart.
- No human trial exists in PubMed or ClinicalTrials.gov.
Selected references
- Peptide substance restoring myocardium function · patents.google.com, 2004
- Peptide regulation of gene expression: a systematic review · PubMed, 2021
- PubChem. Name search "cardiogen" (resolves to L-carnitine, CID 10917) · pubchem.ncbi.nlm.nih.gov
- Senescence-associated secretory phenotype of cardiovascular system cells and inflammaging: perspectives of peptide regulation · PubMed, 2022
- RLS Encyclopedia · rlsnet.ru
- Peptide regulation of gene expression: a systematic review (full text) · pmc.ncbi.nlm.nih.gov
Related pages